Mucormycosis

Close follow-up for worsening of symptoms is required. Weekly computed tomography (CT) scans are strongly recommended to evaluate for disease progression.[12]Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019 Dec;19(12):e405-21. https://pmc.ncbi.nlm.nih.gov/articles/PMC8559573 http://www.ncbi.nlm.nih.gov/pubmed/31699664?tool=bestpractice.com ​  

Monitoring for adverse effects of amphotericin-B is essential. Serial measurement of electrolytes and renal function is advised.

Close follow-up for recurrence is warranted after stopping antifungal therapy.